Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2003
03/20/2003US20030054413 Bioconjugate for use in the detection and measurement of preferential biopolymers
03/20/2003US20030054408 Detection of preferential protein in sample; obtain protein sample, incubate with proteolytic agent, recover protein fragments, incubate with bindng array, detect binding pattern of peptide fragments, compare to control
03/20/2003US20030054405 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054404 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054403 Nucleotide sequences coding membrane protein for use in the treatment, diagnosis and prevention of cancer, nervous system, viral, kidney and inflammatory diseases
03/20/2003US20030054401 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054400 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054398 Isolated human aminotransferase proteins, nucleic acid molecules encoding aminotransferase proteins and uses thereof
03/20/2003US20030054397 Methods and compositions for the detection and treatment of multiple sclerosis
03/20/2003US20030054396 Enzymatic light amplification
03/20/2003US20030054393 Methods for polymorphism identification and profiling
03/20/2003US20030054388 Devices, methods and systems for high-resolution, high-throughput genetic analysis
03/20/2003US20030054387 Metastasis-associated genes
03/20/2003US20030054386 Method for detecting diseases caused by chromosomal imbalances
03/20/2003US20030054384 Integrated systems and methods for diversity generation and screening
03/20/2003US20030054383 Apparatus for use in the generation of preferential nucleotide sequences
03/20/2003US20030054382 Infection of eukaryotic cells with viruses in vitro
03/20/2003US20030054381 Nucleotide sequences for use in forensics and heredity testing; for use in the diagnosis and treatment of respiratory and blood disorder
03/20/2003US20030054380 Diagnosing long qt syndrome; obtain sample, extract nucleotide sequences, incubate with probe, detect polymorphism, presence of polymorphism indicates long qt syndrome
03/20/2003US20030054379 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer, immunological, viral and autoimmune disease
03/20/2003US20030054378 Detecting target nucleotide sequence in sample; obtain sample containing nucleotide sequences, incubate with primers, amplify, incubate with probe, denature, cool, detect signal, presence of signal indicates target sequences
03/20/2003US20030054377 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer, cardovascular and nervous system disorders
03/20/2003US20030054376 Detection of preferential particle in sample using detechable linker; prepare bead complex, incubate with sample, allow associations to occur, cleave space, recover complexed beads
03/20/2003US20030054375 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of connective tissue and cancer disorders
03/20/2003US20030054373 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of prostate cancer
03/20/2003US20030054372 Method for the determination of a nucleic acid using a control
03/20/2003US20030054371 Polymorphic elements in the costimulatory receptor locus and uses thereof
03/20/2003US20030054369 Method for detection of Stachybotrys chartarum in pure culture and field samples using quantitative polymerase chain reaction
03/20/2003US20030054368 Nucleic acids, proteins and antibodies
03/20/2003US20030054367 Method for correlating gene expression profiles with protein expression profiles
03/20/2003US20030054366 Compositions, kits, and methods for identification, assessment, prevention, and therapy of human colon cancer
03/20/2003US20030054364 Generation of preferential nucleotides sequences; obtain nucleotide sequence, delete or insert sequences, incubate with primers, amplify, monitor response to sequence variation
03/20/2003US20030054363 Compositions and methods for the therapy and diagnosis of lung cancer
03/20/2003US20030054362 In vitro cell-based methods for biological validation and pharmacological screening of chemical entities and biologicals
03/20/2003US20030054361 Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system
03/20/2003US20030054360 Detection of prefereential ligands in sample; obtain target protein, incubate with ligand and nucleic reaction mixture, irradiate, immbolize target protein on solid support, amplify nucleotide sequences crosslinked to target protein
03/20/2003US20030054359 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer and nervous system disorders
03/20/2003US20030054358 Nanoparticles having oligonucleotides attached thereto and uses therefor
03/20/2003US20030054357 Monitoring the proliferation of cultured prostate cancer cells; obtain cells, incubate with quercetin, monitor adjustment in gene expression, decrease in androgen receptor gene expression indicate cell proliferation inhibitor
03/20/2003US20030054356 Multiple reporter read-out for bioassays
03/20/2003US20030054355 Detection of target nucleic acid in test sample; obtain target nucleic acid sample, incubate with piezoelectric biosensor, incubate with probe, extend probe and measure signal from biosensor
03/20/2003US20030054352 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054351 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054350 TCF-1 nucleotide sequence variation
03/20/2003US20030054349 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054347 Nucleotide sequences coding polypeptide for use in the treatment of vision defects
03/20/2003US20030054346 Screening nucleotide sequence for hybridization activity; obtain nucleotide sequences, determine sequence, compare to hybrid pair, detect segment of chromosome with complimentary sequences
03/20/2003US20030054345 Compositions and methods for the diagnosis and treatment of neuropsychiatric disorders, including schizophrenia
03/20/2003US20030054344 Method for generating ultra-fine spotted arrays
03/20/2003US20030054343 Diagnosing hypertrophic cardiomyopathy; obtain cell sample, extract nucleotide sequences, amplify, determine sequence of sample, detect presence or absence of mutation in sample
03/20/2003US20030054342 Measurements of multiple molecules using a cryoarray
03/20/2003US20030054341 Viral nucleotide sequences for use in diagnosis, prevention and treatment of viral diseases
03/20/2003US20030054339 Detection of mutation associated with resistance to viricides; obtain viral sample, extract nucleotide sequences, incubate with probe, compare to control, sequence, monitor response to viricide
03/20/2003US20030054338 Classification of microorganism; obtain microorganism, extract nucleotide sequences, cut with enzymes, incubate with probe, detect signal, classify microorganisms
03/20/2003US20030054334 Medical and diagnostic use of a specific co-activator for human nuclear receptors
03/20/2003US20030054002 Screening, therapy for autoimmune disease
03/20/2003US20030054001 Antibody, antigen complex
03/20/2003US20030054000 Anti-pathogen system and methods of use thereof
03/20/2003US20030053951 Use of non-invasive imaging technologies to monitor in vivo gene-expression
03/20/2003US20030053950 Metabolic phenotyping via administration of probe for HMG CoA reductase inhibitor (hydroxy-3-methylglutaryl/3-coenzyme A); comprises microgravimetric sensors
03/20/2003US20030052003 Cast analyte diffusion-limiting membranes using photopolymerizable hydrophylic monomers
03/20/2003CA2783186A1 Assay buffer, compositions containing the same, and methods of using the same
03/20/2003CA2743332A1 Method and apparatus for assay based on light diffraction
03/20/2003CA2714094A1 Methods and apparatus for conducting multiple measurements on a sample
03/20/2003CA2488684A1 Glucosyltransferases which glucosylate abscisic acid
03/20/2003CA2466896A1 Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
03/20/2003CA2460496A1 Methods of detection of conformational change in a nucleic acid duplex by treatment with oxidising or reactive agent as a result of exposure to environmental or chemical conditions
03/20/2003CA2460425A1 Novel nucleic acids and polypeptides
03/20/2003CA2460117A1 Expression profiling in the intact human heart
03/20/2003CA2460092A1 A method of diagnosis and treatment and agents useful for same
03/20/2003CA2460049A1 Enhanced resolution of tumor metastasis
03/20/2003CA2459945A1 Methods of screening molecules that are used to prevent cardiovascular diseases
03/20/2003CA2459893A1 Methods and apparatus for conducting multiple measurements on a sample
03/20/2003CA2459731A1 Genetic analysis of biological samples in arrayed expanded representations of their nucleic acids
03/20/2003CA2459729A1 Methods for producing ex vivo models for inflammatory disease and uses thereof
03/20/2003CA2459560A1 Methods of kidney transplantation utilizing developing nephric tissue
03/20/2003CA2459462A1 Microcantilever apparatus and methods for detection of enzymes
03/20/2003CA2459373A1 Method of evaluating efficacy of nucleic acid therapy
03/20/2003CA2459318A1 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003CA2459310A1 Method and composition for treating immune complex associated disorders
03/20/2003CA2458302A1 New assay for inhibitors of translocases
03/20/2003CA2455990A1 Methods for diagnosing and treating diseases and conditions associated with protein kinase c.lambda.
03/20/2003CA2451454A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003CA2451254A1 Novel proteins and nucleic acids encoding same
03/19/2003EP1293576A1 Compositions and methods to identify haplotypes
03/19/2003EP1293575A2 Universal test system and methods of use thereof for indentifying multiple families of microorganisms
03/19/2003EP1293574A2 Reagents, methods and devices for detecting analytes
03/19/2003EP1293570A2 Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH)
03/19/2003EP1293569A2 Full-length cDNAs
03/19/2003EP1293565A2 Mammalian telomerase RNA component
03/19/2003EP1293562A1 Fungal glyoxal oxidases
03/19/2003EP1292830A2 Method for identifying insulin mimics or antagonists
03/19/2003EP1292829A1 No wash bead assay, kit and procedure
03/19/2003EP1292827A1 T2r taste receptors and genes encoding same
03/19/2003EP1292712A1 Means and methods for monitoring antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
03/19/2003EP1292711A2 Method for the high-parallel analysis of polymorphisms
03/19/2003EP1292710A2 Matrix screening method
03/19/2003EP1292707A2 Oligonucleotides or pna oligomers and a method for detecting the methylation state of genomic dna in a parallel manner
03/19/2003EP1292706A2 Method of identifying ginko biloba in a plant extract by gene profiling
03/19/2003EP1292705A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow